We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COOP
976
DELISTED
Mr. Cooper
COOP
| $3.28M | 0.01% |
+261,927
| New | +$3.22M |
|
|
EGIO
977
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.26M | 0.01% |
19,954
+18,151
| +1,007% | +$2.87M |
|
978
Dana Inc
DAN
$3.21B
| $3.25M | 0.01% |
+178,603
| New | +$2.98M |
|
|
FCRD
979
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $3.25M | 0.01% |
515,002
+37,488
| +8% | +$253K |
|
980
Nektar Therapeutics
NKTR
$2.53B
| $3.25M | 0.01% |
+10,033
| New | +$2.91M |
|
981
Target
TGT
$69B
| $3.24M | 0.01% |
25,300
-517,828
| -95% | -$60.8M |
|
|
AQUA
982
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $3.23M | 0.01% |
+170,734
| New | +$3.06M |
|
|
MSB
983
Mesabi Trust
MSB
$306M
| $3.17M | 0.01% |
134,681
+1,012
| +0.8% | +$23.5K |
|
984
The Bancorp
TBBK
$2.81B
| $3.17M | 0.01% |
244,271
+199,300
| +443% | +$2.24M |
|
985
KRONOS Worldwide
KRO
$977M
| $3.17M | 0.01% |
+236,240
| New | +$3.1M |
|
|
ATRS
986
DELISTED
Antares Pharma, Inc.
ATRS
| $3.14M | 0.01% |
+668,697
| New | +$2.74M |
|
987
Alpha and Omega Semiconductor
AOSL
$1.03B
| $3.14M | 0.01% |
230,445
+47,669
| +26% | +$602K |
|
|
THR
988
DELISTED
Thermon Group Holdings
THR
| $3.13M | 0.01% |
116,922
+68,229
| +140% | +$1.72M |
|
989
Encore Capital Group
ECPG
$2.01B
| $3.11M | 0.01% |
+87,996
| New | +$3.08M |
|
990
Ezcorp Inc
EZPW
$1.67B
| $3.11M | 0.01% |
456,192
+436,792
| +2,252% | +$2.51M |
|
991
NCR Voyix
VYX
$1.09B
| $3.11M | 0.01% |
144,203
-5,920
| -4% | -$115K |
|
992
MYR Group
MYRG
$5.14B
| $3.09M | 0.01% |
94,704
+35,984
| +61% | +$1.19M |
|
993
Provident Financial Services
PFS
$3.17B
| $3.09M | 0.01% |
125,184
+107,184
| +595% | +$2.65M |
|
|
AYX
994
DELISTED
Alteryx Inc
AYX
| $3.08M | 0.01% |
+30,787
| New | +$3.13M |
|
995
TransDigm Group
TDG
$67.6B
| $3.08M | 0.01% |
5,500
+3,900
| +244% | +$2.13M |
|
996
Plexus
PLXS
$7.16B
| $3.08M | 0.01% |
+40,000
| New | +$2.9M |
|
997
CONMED
CNMD
$1.48B
| $3.06M | 0.01% |
+27,400
| New | +$2.92M |
|
|
CSII
998
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.05M | 0.01% |
+62,731
| New | +$2.86M |
|
999
Preferred Bank
PFBC
$1.25B
| $3.05M | 0.01% |
50,705
+31,476
| +164% | +$1.73M |
|
|
TEN
1000
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $3.05M | 0.01% |
232,617
+218,385
| +1,534% | +$2.86M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.